Search Results

The superantigen SEA binds to human γδ T cell receptor and activates γδ T cells with moderate MHC class II dependence

• Authors : Uzunçayır, Sibel; Petruk, Ganna; Mata Forsberg, Manuel

Subjects: SEA; Superantigen; TRGV9/TRDV2

• Source: Molecular Immunology EXODIAB: Excellence of Diabetes Research in Sweden. 181:1-8

Record details

An exploratory study on the differential diagnostic indicators between adult systemic EBV-positive T-cell lymphoproliferative disorders and angioimmunoblastic T-cell lymphoma with multiple EBV infections.

• Authors : Zheng, Xiaodan^1,2 (AUTHOR); Zheng, Yuanyuan¹ (AUTHOR); Zhang, Yanlin¹ (AUTHOR)

• Source: Infectious Agents & Cancer. 1/22/2025, Vol. 20 Issue 1, p1-13. 13p.

Record details

High prevalence of FAP plus cancer-associated fibroblasts predicts poor outcome in patients with high-grade serous ovarian cancer with high CD8 T-cell density

• Authors : Corvigno, Sara; Fernebro, Josefin; Severin-Karisson, Josefin

Subjects: FAP; T cell; Fibroblast

• Source: Gynecologic Oncology. 193:148-155

Record details

T-cell receptor structures and predictive models reveal comparable alpha and beta chain structural diversity despite differing genetic complexity.

• Authors : Quast NP; Department of Statistics, University of Oxford, Oxford, UK.; Abanades B

Subjects: Receptors, Antigen, T-Cell, alpha-beta*/Receptors, Antigen, T-Cell, alpha-beta*/Receptors, Antigen, T-Cell, alpha-beta*/genetics ; Receptors, Antigen, T-Cell, alpha-beta*/Receptors, Antigen, T-Cell, alpha-beta*/Receptors, Antigen, T-Cell, alpha-beta*/chemistry; Humans

• Source: Communications biology [Commun Biol] 2025 Mar 04; Vol. 8 (1), pp. 362. Date of Electronic Publication: 2025 Mar 04.Publisher: Nature Publishing Group UK Country of Publication: England NLM ID: 101719179 Publication Model: Electronic Cited Medium: Internet ISSN:

Record details

T-Cell Receptor/CD3 Downregulation and Impaired Signaling in HTLV-1-Infected CD4+ T Cells of HAM Patients.

• Authors : Nozuma, Satoshi¹ (AUTHOR); Matsuzaki, Toshio² (AUTHOR); Tanaka, Masakazu^1,2 (AUTHOR)

Subjects: *HTLV-I; *ADULT T-cell leukemia; *T cells

• Source: International Journal of Molecular Sciences. Feb2025, Vol. 26 Issue 4, p1706. 13p.

Record details

Results from an open-label phase 2a study of cerdulatinib, a dual spleen tyrosine kinase/janus kinase inhibitor, in relapsed/refractory peripheral T-cell lymphoma.

• Authors : Horwitz, Steven M.¹ (AUTHOR) ; Feldman, Tatyana A.² (AUTHOR); Ye, Jing Christine³ (AUTHOR)

• Source: Leukemia & Lymphoma. Feb2025, p1-11. 11p. 3 Illustrations.

Record details

TCR3d 2.0: expanding the T cell receptor structure database with new structures, tools and interactions.

• Authors : Lin, Valerie^1,2 (AUTHOR); Cheung, Melyssa^2,3 (AUTHOR); Gowthaman, Ragul^1,2 (AUTHOR)

Subjects: *T cell receptors; *IMMUNE response; *IMMUNE complexes

• Source: Nucleic Acids Research. 1/6/2025, Vol. 53 Issue D1, pD604-D608. 5p.

Record details

Variance in development of early and late cardiotoxicities in patients with lymphoma and myeloma receiving CAR T-cell therapies.

• Authors : Grunblatt, Eli¹ (AUTHOR); Meng, Zhiying² (AUTHOR); Baldridge, Abigail S.² (AUTHOR)

• Source: Leukemia & Lymphoma. Jan2025, p1-11. 11p. 4 Illustrations.

Record details

Pharmacological Modulation of the Unfolded Protein Response as a Therapeutic Approach in Cutaneous T-Cell Lymphoma.

• Authors : St. Thomas, Nadia¹ (AUTHOR) ; Christopher, Benjamin N.¹ (AUTHOR) ; Reyes, Leticia¹ (AUTHOR)

• Source: Biomolecules (2218-273X). Jan2025, Vol. 15 Issue 1, p76. 22p.

Record details

Pegylated interferon α-2a in the management of cutaneous T-cell lymphoma.

• Authors : Asermouh, Marwa¹ ; Khabba, ChaïmaeAït¹; Senouci, Karima¹

• Source: Our Dermatology Online / Nasza Dermatologia Online. Jan2025, Vol. 16 Issue 1, p72-75. 4p.

Record details